Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect

JAMA Psychiatry. 2019 Jun 1;76(6):657-658. doi: 10.1001/jamapsychiatry.2019.0766.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alcoholism*
  • Antidepressive Agents
  • Depression
  • Humans
  • Ketamine*
  • Naltrexone
  • Receptors, Opioid

Substances

  • Antidepressive Agents
  • Receptors, Opioid
  • Naltrexone
  • Ketamine